Coronary artery embolism following cancer chemotherapy.
A 16-year-old patient underwent partial gastrectomy for leiomyosarcoma of the stomach. Following resection, he received combination chemotherapy that included Adriamycin and dimethyltriazenoimidazole carboxamide (DTIC), with the cumulative Adriamycin dose being 405 mg/m2. The patient was subsequently treated with vincristine, actinomycin D, and cyclophosphamide. Six hours after receiving his fourth dose of cyclophosphamide, the patient developed signs and symptoms of acute anterior wall myocardial infarction. Although he recovered from this initial cardiac event, he subsequently experienced several additional episodes of vascular occlusion involving the cerebral, femoral, coronary, and pulmonary arteries. Cardiac catheterization demonstrated all coronary arteries to be normal. Both ventricles were hypokinetic, and bilateral mural thrombi were demonstrated; these were the presumed source of the embolic phenomena. To our knowledge, this is the first description of repeated coronary artery embolization following cancer chemotherapy in a patient without evidence of preexisting cardiac abnormalities.
Ali
M K
MK
Cardiopulmonary Section, University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Ewer
M S
MS
Cangir
A
A
Fisher
D J
DJ
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000139:chemically induced*; D003328:Coronary Thrombosis / Q000139:chemically induced*; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004562:Electrocardiography; D005743:Gastrectomy; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008297:Male; D013274:Stomach Neoplasms / Q000188:drug therapy*
D003606:Dacarbazine; D004317:Doxorubicin